title: Trends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010.
abstract: BACKGROUND
  Trends in the prevalence and control of diabetes defined by hemoglobin A1c (HbA1c) levels are important for health care policy and planning.
  
  
  OBJECTIVE
  To update trends in the prevalence of diabetes, prediabetes, and glycemic control.
  
  
  METHODS
  Cross-sectional.
  
  
  METHODS
  NHANES (National Health and Nutrition Examination Survey) in 1988-1994 and 1999-2010.
  
  
  METHODS
  Adults aged 20 years or older.
  
  
  METHODS
  We used calibrated HbA1c levels to define undiagnosed diabetes (≥6.5%); prediabetes (5.7% to 6.4%); and, among persons with diagnosed diabetes, glycemic control (&lt;7.0% or &lt;8.0%). Trends in HbA1c categories were compared with fasting glucose levels (≥7.0 mmol/L [≥126 mg/dL] and 5.6 to 6.9 mmol/L [100 to 125 mg/dL]).
  
  
  RESULTS
  In 2010, approximately 21 million U.S. adults aged 20 years or older had total confirmed diabetes (self-reported diabetes or diagnostic levels for both fasting glucose and calibrated HbA1c). During 2 decades, the prevalence of total confirmed diabetes increased, but the prevalence of undiagnosed diabetes remained fairly stable, reducing the proportion of total diabetes cases that are undiagnosed to 11% in 2005-2010. The prevalence of prediabetes was lower when defined by calibrated HbA1c levels than when defined by fasting glucose levels but has increased from 5.8% in 1988-1994 to 12.4% in 2005-2010 when defined by HbA1c levels. Glycemic control improved overall, but total diabetes prevalence was greater and diabetes was less controlled among non-Hispanic blacks and Mexican Americans compared with non-Hispanic whites.
  
  
  CONCLUSIONS
  Cross-sectional design.
  
  
  CONCLUSIONS
  Over the past 2 decades, the prevalence of total diabetes has increased substantially. However, the proportion of undiagnosed diabetes cases decreased, suggesting improvements in screening and diagnosis. Among the growing number of persons with diagnosed diabetes, glycemic control improved but remains a challenge, particularly among non-Hispanic blacks and Mexican Americans.
  
  
  BACKGROUND
  National Institutes of Health.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Selvin
authors.forename: Christina M
authors.initials: CM
authors.lastname: Parrinello
authors.forename: David B
authors.initials: DB
authors.lastname: Sacks
authors.forename: Josef
authors.initials: J
authors.lastname: Coresh
mesh_terms: D000328:Adult; D000368:Aged; D044383:Black People / Q000706:statistics & numerical data; D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism*; D015897:Comorbidity; D003430:Cross-Sectional Studies; D003920:Diabetes Mellitus / Q000097:blood / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control*; D005215:Fasting; D005260:Female; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008297:Male; D017058:Mexican Americans / Q000706:statistics & numerical data; D009749:Nutrition Surveys; D009765:Obesity / Q000453:epidemiology; D011236:Prediabetic State / Q000097:blood / Q000453:epidemiology* / Q000517:prevention & control*; D015995:Prevalence; D014481:United States / Q000453:epidemiology; D055815:Young Adult; D001741:Black or African American
chemical_list: D001786:Blood Glucose; D006442:Glycated Hemoglobin
references.citation: Ann Intern Med. 1994 Dec 15;121(12):912-8
references.pmid: 7978716
references.citation: Int J Obes Relat Metab Disord. 1998 Jan;22(1):39-47
references.pmid: 9481598
references.citation: J Am Geriatr Soc. 2010 Apr;58(4):724-30
references.pmid: 20398154
references.citation: N Engl J Med. 2013 Aug 8;369(6):540-8
references.pmid: 23924004
references.citation: Diabetes Care. 2000 Sep;23(9):1278-83
references.pmid: 10977060
references.citation: Lancet Neurol. 2006 Jan;5(1):64-74
references.pmid: 16361024
references.citation: Diabetes Care. 2013 Aug;36(8):2286-93
references.pmid: 23603918
references.citation: Diabetes Care. 2010 Oct;33(10):2190-5
references.pmid: 20628087
references.citation: Diabetes Care. 2013 May;36(5):1153-8
references.pmid: 23248194
references.citation: Diabetes Care. 2013 Aug;36(8):2139-41
references.pmid: 23881964
references.citation: Diabetes Care. 2011 Feb;34(2):353-7
references.pmid: 21216863
references.citation: Diabetes Care. 2010 Jan;33 Suppl 1:S11-61
references.pmid: 20042772
references.citation: Diabetologia. 2011 Jul;54(7):1645-52
references.pmid: 21360189
references.citation: Diabetes Care. 2011 Jan;34(1):84-9
references.pmid: 20855549
references.citation: J Clin Exp Neuropsychol. 2012;34(7):758-72
references.pmid: 22540849
references.citation: Diabetes Care. 2013 Jan;36 Suppl 1:S11-66
references.pmid: 23264422
references.citation: Diabetes Care. 2010 May;33(5):1055-60
references.pmid: 20185736
references.citation: N Engl J Med. 2011 Mar 03;364(9):829-841
references.pmid: 21366474
references.citation: JAMA. 2010 Jan 20;303(3):235-41
references.pmid: 20071471
references.citation: Arch Intern Med. 2007 Jul 23;167(14):1545-51
references.pmid: 17646610
references.citation: J Am Soc Nephrol. 2002 Sep;13(9):2363-70
references.pmid: 12191981
references.citation: Diabetes Care. 2013 Mar;36(3):569-73
references.pmid: 23069841
references.citation: Lancet. 2011 Jul 9;378(9786):147-55
references.pmid: 21705064
references.citation: Diabetes Care. 2007 Feb;30(2):325-31
references.pmid: 17259502
references.citation: Am J Epidemiol. 2012 Oct 15;176(8):738-43
references.pmid: 23013620
references.citation: N Engl J Med. 2012 Mar 29;366(13):1209-17
references.pmid: 22455415
references.citation: MMWR Morb Mortal Wkly Rep. 1997 Oct 31;46(43):1014-8
references.pmid: 9367135
references.citation: N Engl J Med. 2010 Mar 4;362(9):800-11
references.pmid: 20200384
references.citation: Clin Nephrol. 2012 Apr;77(4):332-44
references.pmid: 22445478
references.citation: Diabetes Care. 2003 Jan;26(1):206-10
references.pmid: 12502682
references.citation: Ann Epidemiol. 2004 Aug;14(7):507-16
references.pmid: 15301787